<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Vasgen Limited Selected to Participate in Technology Strategy Board Showcase at BioTrinity 2014: 12-14/05/2014</title>
	<atom:link href="https://vasgen.co.uk/vasgen-limited-selected-to-participate-in-technology-strategy-board-showcase-at-biotrinity-2014-12-14052014/feed/" rel="self" type="application/rss+xml" />
	<link>https://vasgen.co.uk/vasgen-limited-selected-to-participate-in-technology-strategy-board-showcase-at-biotrinity-2014-12-14052014/</link>
	<description>Innovative ocular and cancer therapeutics</description>
	<lastBuildDate></lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
